Quest Diagnostics Inc Future Amortization Expense, Remainder of Fiscal Year (Deprecated 2012-01-31)
Quest Diagnostics Inc (DGX) reported Future Amortization Expense, Remainder of Fiscal Year (Deprecated 2012-01-31) of $59.86 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-04-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FutureAmortizationExpenseRemainderOfFiscalYear · last filed 2012-04-27
- Quest Diagnostics Inc future amortization expense, remainder of fiscal year (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $59.86M.
| Period end | Future Amortization Expense, Remainder of Fiscal Year (Deprecated 2012-01-31) 3 month |
|---|---|
| 2012-03-31 | $59.86M 10-Q · filed 2012-04-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |